Skip to content
2000
Volume 17, Issue 2
  • ISSN: 1568-0096
  • E-ISSN: 1873-5576

Abstract

Compared to normal cells, usually cancer cells are under higher oxidative stress. Elevating intracellular levels of reactive oxygen species (ROS) by introducing excessive ROS or inhibiting antioxidant system may enhance selectively of cancer cell killing by ROS-modulating agents through stress sensitization or stress overload. Meanwhile due to the adaptive response, normal cells may be capable of maintaining redox homeostasis under exogenous ROS. Here we review ROS-modulating agents in different mechanisms and classify them into groups by various targets for illustrating more clearly. At last, we discuss their side effects and the potential troubles of developing these agents and argue that might be an effective strategy for further exploring to modulate the unique redox regulatory mechanisms of cancer cells.

Loading

Article metrics loading...

/content/journals/ccdt/10.2174/1568009616666160216125833
2017-02-01
2025-06-13
Loading full text...

Full text loading...

/content/journals/ccdt/10.2174/1568009616666160216125833
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test